Vanguard Group Inc Caribou Biosciences, Inc. Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,565,445 shares of CRBU stock, worth $5.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,565,445
Previous 4,618,268 1.14%
Holding current value
$5.98 Million
Previous $9.01 Million 19.39%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$1.59 - $2.79 $83,988 - $147,376
-52,823 Reduced 1.14%
4,565,445 $7.26 Million
Q3 2024

Nov 13, 2024
BUY
$1.56 - $2.73 $114,756 - $200,824
73,562 Added 1.62%
4,618,268 $9.01 Million
Q2 2024

Aug 13, 2024
BUY
$1.62 - $5.05 $702,935 - $2.19 Million
433,911 Added 10.56%
4,544,706 $7.45 Million
Q1 2024

May 10, 2024
BUY
$4.82 - $8.26 $716,979 - $1.23 Million
148,751 Added 3.75%
4,110,795 $21.1 Million
Q4 2023

Feb 14, 2024
BUY
$3.58 - $6.25 $500,816 - $874,331
139,893 Added 3.66%
3,962,044 $22.7 Million
Q3 2023

Nov 14, 2023
BUY
$4.08 - $8.14 $5.15 Million - $10.3 Million
1,261,920 Added 49.29%
3,822,151 $18.3 Million
Q2 2023

Aug 14, 2023
SELL
$4.04 - $5.47 $185,153 - $250,690
-45,830 Reduced 1.76%
2,560,231 $10.9 Million
Q1 2023

May 15, 2023
BUY
$4.3 - $7.78 $111,129 - $201,066
25,844 Added 1.0%
2,606,061 $13.8 Million
Q4 2022

Feb 10, 2023
BUY
$5.57 - $11.01 $149,214 - $294,946
26,789 Added 1.05%
2,580,217 $16.2 Million
Q3 2022

Nov 14, 2022
BUY
$5.34 - $12.79 $3 Million - $7.18 Million
561,065 Added 28.16%
2,553,428 $26.9 Million
Q2 2022

Aug 12, 2022
SELL
$5.1 - $9.74 $46,874 - $89,520
-9,191 Reduced 0.46%
1,992,363 $10.8 Million
Q1 2022

May 13, 2022
BUY
$8.42 - $15.32 $9.15 Million - $16.7 Million
1,087,038 Added 118.86%
2,001,554 $18.4 Million
Q4 2021

Feb 14, 2022
SELL
$14.59 - $23.26 $319,287 - $509,021
-21,884 Reduced 2.34%
914,516 $13.8 Million
Q3 2021

Nov 12, 2021
BUY
$15.75 - $30.29 $14.7 Million - $28.4 Million
936,400 New
936,400 $22.4 Million

Others Institutions Holding CRBU

# of Institutions
138
Shares Held
54.4M
Call Options Held
21.2K
Put Options Held
96.4K
View Full List

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $79.7M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email